Loading...

Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

BACKGROUND: The aim of this study was to assess and compare the Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) and the Choi criteria in evaluating the early response of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) treated with sunitinib. METHODS: Eightee...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMC Cancer
Main Authors: Luo, Yanji, Chen, Jie, Huang, Kun, Lin, Yuan, Chen, Minhu, Xu, Ling, Li, Zi-Ping, Feng, Shi-Ting
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5324282/
https://ncbi.nlm.nih.gov/pubmed/28231773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3150-7
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!